DOUGLAS REED

Profile

First Name

: DOUGLAS

Middle Name

:

Last Name

: REED

Related Companies
Titles
Company Name
Related People
DIRECTOR
SPINEWORKS MEDICAL INC
PAUL CHIRICO, PAUL E. CHIRICO, GARY GRENTER, MIKE HENSON, PATRICK LYNN, BEAT MERZ
DIRECTOR
SPINEALIGN MEDICAL INC
PAUL CHIRICO, PAUL E. CHIRICO, GARY GRENTER, MIKE HENSON, PATRICK LYNN, BEAT MERZ
DIRECTOR
VIAMET PHARMACEUTICALS INC
GARHENG KONG, NEIL MOORE, JAMES ROSEN, ROBERT SCHOTZINGER, LAUREN SILVERMAN, S. EDWARD TORRES, ANDREW VON ESCHENBACH, WILLIAM T. WHITE, III
DIRECTOR
PHASEBIO PHARMACEUTICALS INC
JAMES BARRETT, ASHUTOSH CHILKOTI, GUY FISH, MICHAEL GUTCH, NANCY HUTSON, ROBERT INGRAM, JUSTIN KLEIN, THOMAS K LAUNDON, CAROLINE LOEWY, JONATHAN MOW, BIBHASH MUKHOPADHYAY, CHRISTOPHER PRIOR, TYRELL RIVERS, CRAIG ROSEN, JOHN SHARP, WILL SHEN, JOEL SUSSMAN, CLAY THORP, LINDA TUFTS, ASISH K XAVIER, ASISH K. XAVIER
DIRECTOR
TETRALOGIC PHARMACEUTICALS CORP
BRENDA GAVIN, JOHN M. GILL, JAMES E. GOLDSCHMIDT, HELGA KAUTSKY, JACK LASERSOHN, MARK A. MCKINLAY, GEORGE MCLENDON, DOUGLAS ONSI, ANDREW PECORA, PAUL SCHMITT, MICHAEL STEINMETZ, DAVID E. WENG, HAROLD WERNER, JAMES WOODY, JIM WOODY
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS IV, LP
JOHN C. CRUMPLER, - HATTERAS VENTURE ADVISORS IV, LLC, ROBERT A. INGRAM, KENNETH B. LEE, JR., CLAY B. THORP
DIRECTOR
VIAMET PHARMACEUTICALS HOLDINGS LLC
KENNETH BAHK, JEFFREY EDWARDS, ADRIAN HOWD, ROBERT INGRAM, RICHARD KATZ, G. KELLY MARTIN, NEIL MOORE, JAMES ROSEN, ROBERT J. SCHOTZINGER, M.D., PH.D., LAUREN SILVERMAN, S. EDWARD TORRES, PHILIP R. TRACY, ANDREW VON ESCHENBACH, STEVEN D. WEINSTEIN, WILLIAM T. WHITE III, KRISTOPHER A. WOOD
DIRECTOR
NEUROTRONIK, INC.
MUDIT JAIN, R. FREDERICK MCCOY, JR., DAVID STEINHAUS
DIRECTOR
SIDERIS PHARMACEUTICALS, INC.
ANSBERT K GADICKE, THOMAS NEENAN, KAZUMI SHIOSAKI
DIRECTOR
COFERON, INC.
KAPIL DHINGRA, MICHAEL GARGANO, COLIN GODDARD, ALAN LEWIS, VIREN MEHTA, MANEESH PINGLE, JAMES SCHULZ, MARK SIMON, DEREK SMALL, GEOFF SMITH, JUTTA WANNER
DIRECTOR
INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
FRED ESHELMAN, RICHARD KENT, THOMAS LAUNDON, WILLIAM MOORE, CHARLES OSBORNE, JAMES ROSEN, ROBERT SCHOTZINGER, S. EDWARD TORRES, ANDREW VON ESCHENBACH, STEVEN WEINSTEIN, KRISTOPHER WOOD
DIRECTOR
BLINKBIO, INC.
KAPIL DHINGRA, MICHAEL GARGANO, COLIN GODDARD, ALAN LEWIS, VIREN MEHTA, MANEESH PINGLE, JAMES SCHULZ, MARK SIMON, DEREK SMALL, GEOFF SMITH, JUTTA WANNER
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS V, LP
JOHN C. CRUMPLER, - HATTERAS VENTURE ADVISORS V, LLC, ROBERT A. INGRAM, CHRISTY SHAFFER, CLAY B. THORP
DIRECTOR
QPEX BIOPHARMA, INC.
DANIEL BURGESS, MICHAEL N. DUDLEY, CAROL GALLAGHER, TERRY GOULD, KEVIN LI
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS VI, LP
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VI, LLC, ROBERT A. INGRAM, CHRISTY SHAFFER, JEFFREY TERRELL, CLAY B. THORP
EXECUTIVE OFFICER
EMX ROYALTY CORP
VALERIE BARLOW, BRIAN ERIC BAYLEY, KIM CHARISSE CASSWELL, CHRISTINA CEPELIAUSKAS, DAVID MORRELL COLE, ROCIO ECHEGARAY, MERRIT STEPHEN ENDERS, BRIAN KENNETH LEVET, GEORGE KOK CHEAN LIM, S.C. SUNNY LOWE, HENRIK LUNDIN, LARRY MINORU OKADA, MICHAEL DEMPSEY WINN
DIRECTOR
AVIVOMED INC.
CASPER DE CLERCQ, MUDIT K. JAIN, STEPHEN MASSON, PAUL MAZANEC, THERESA C. PAPPAS, KETAN PATEL
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS VII, LP
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VII, LLC, ROBERT A. INGRAM, CHRISTY SHAFFER, JEFFREY TERRELL, CLAY B. THORP
EXECUTIVE OFFICER
HATTERAS OPPORTUNITY FUND I, LP
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VII, LLC, ROBERT A. INGRAM, CHRISTY SHAFFER, JEFFREY TERRELL, CLAY B. THORP
EXECUTIVE OFFICER
HATTERAS CREATE SF SPV, LLC
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VI, LLC, CHRISTY SHAFFER, CLAY B. THORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2026-04-16 
2026-04-13
D
Link
INVESTING 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-02 
2024-03-07
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-02 
2023-09-08
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2023-02-03
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-02 
2023-02-02
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2021-11-18
D
Link
OTHER 
METAL MINING [1000] 
DECLINE TO DISCLOSE 
Equity 
2021-11-05 
2021-11-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-03 
2020-10-15
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-01 
2020-02-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-31 
2019-12-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2019-12-11 
2019-08-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-02 
2019-04-15
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-01 
2018-10-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-02 
2017-07-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-07-11 
2017-04-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-07 
2017-03-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
2016-10-28
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2016-10-17 
2016-09-28
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-09-21 
2016-09-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-09 
2015-08-24
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-07 
2015-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-08-05 
2015-04-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-09 
2014-12-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-11-26 
2014-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-10-10 
2014-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-05-07 
2014-03-12
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-26 
2013-10-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-10 
2013-06-17
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-02 
2013-06-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-31 
2012-12-28
D/A
Link
POOLED INVESTMENT FUND 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-10 
2012-12-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-11-29 
2012-10-16
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-02 
2012-01-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-30 
2011-08-24
D
Link
POOLED INVESTMENT FUND 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-10 
2011-05-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-20 
2011-02-18
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-23 
2011-01-24
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2010-02-12 
2010-08-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-26 
2010-02-25
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2010-02-12 
2010-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-22 
2009-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-03 
2009-07-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-23 
2009-05-11
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-10 
2009-03-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-10